MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

    M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

    Objective: 1) To compare the cognitive and neuropsychological manifestations between the patients with PSP and PD. 2) To find out the severity of caregivers distress…
  • 2016 International Congress

    Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

    F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

    Objective: To test whether subjective sleep perception is associated with objective sleep parameters by comparing video-polysomnographic (vPSG) data from Parkinson's disease (PD) patients with scorings…
  • 2016 International Congress

    Clinical and MRI-characteristics of drug-induced parkinsonism in Uzbekistan

    A. Umarov, A. Prokhorova, G. Rakhimbaeva, K. Mirzaeva, N. Tuychibaeva (Tashkent, Uzbekistan)

    Objective: To establish clinical and MRI morphometric differences between Parkinson's disease (PD) and Drug-induced parkinsonism (DP). Background: DP – is the most known side effect…
  • 2016 International Congress

    The importance of Ishihara testing in early diagnosing of Parkinson’s disease

    S. Mirdedaev, K. Mirzayeva, D. Baykhonova (Tashkent, Uzbekistan)

    Objective: Studying the importance of color differentiating in order to detect PD at earlier stages. Methods: Ishihara Test (IT) was experimented in 30 patients at…
  • 2016 International Congress

    Defining the pathology underlying cortico-basal syndrome: A European study

    R.C. Lamb, M.C. Darvell, J.D.S. Woodside, J.D. Rohrer, A.J. Lees, H.R. Morris (London, United Kingdom)

    Objective: To understand how clinical and biological features can help us define and explain the varying pathology that underlies corticobasal syndrome (CBS). Background: Corticobasal degeneration…
  • 2016 International Congress

    Chronic acquired hepatocerebral degeneration: Efficacy of liver transplatation in 10 patients

    J. Martins, J. Alves, S. Cavaco, J. Gandara, S. Ferreira, H. Pessegueiro, M. Magalhães (Porto, Portugal)

    Objective: To determine the effect of liver transplantation (LT) on neurological symptoms in patients with chronic acquired hepatocerebral degeneration (CAHD). Background: CAHD is a rare…
  • 2016 International Congress

    Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report

    E.M. Gatto, J.L. Etcheverry, N. Basack, L. Aversa, N. Fernández Escobar, B. Soberón, A. Sanguinetti, M. Cesarini, G. Drelichman, E.M. Gatto (Buenos Aires, Argentina)

    Objective: To describe prodromal symptoms or signs of Parkinson's disease (PD) in a type 1 Gaucher Disease cohort (GD). Background: Mutations in the acid b-glucocerebrosidase…
  • 2016 International Congress

    Idiopathic Parkinson’s disease presenting with dysphagia 15 years before PD diagnosis

    T. Munteanu, C. Goggins, D. Costigan, J. Molloy, T. O'Dwyer, T. Lynch (Dublin, Ireland)

    Objective: To describe an atypical presentation of Idiopathic Parkinson's disease. Background: Dysphagia is a commonly reported “non-motor” feature of Idiopathic Parkinson's disease (IPD), which usually…
  • 2016 International Congress

    Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia

    Y. Mironova, I. Zhukova, N. Zhukova, V. Alifirova, O. Izhboldina, A. Latypova, M. Nikitina (Tomsk, Russia)

    Objective: The aim of this study was to evaluate results of using Parkinson's Well-Being Map (WBM) in assessment of digestive and gut dysfunction in patients…
  • 2016 International Congress

    Association of mood and affective disorders with pain in Parkinson’s disease

    J.S. Kim, W. Jang, J. Park, E. Oh, J. Youn, J.W. Cho (Seoul, Korea)

    Objective: We aimed to compare the severity of depression and anxiety in Parkinson's disease (PD) patients with pain and without pain, and demonstrate the relationship…
  • « Previous Page
  • 1
  • …
  • 336
  • 337
  • 338
  • 339
  • 340
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley